OBJECTIVE: Compared with nondiabetic subjects, type 2 diabetic subjects are metabolically inflexible with impaired fasting fat oxidation and impaired carbohydrate oxidation during a hyperinsulinemic clamp. We hypothesized that impaired insulin-stimulated glucose oxidation is a consequence of the lower cellular glucose uptake rate in type 2 diabetes. Therefore, we compared metabolic flexibility to glucose adjusted for glucose disposal rate in nondiabetic versus type 2 diabetic subjects and in the latter group after 1 year of lifestyle intervention (the Look AHEAD [Action For Health in Diabetes] trial). RESEARCH DESIGN AND METHODS: Macronutrient oxidation rates under fasting and hyperinsulinemic conditions (clamp at 80 mU/m(2) per min), body composition (dual-energy X-ray absorptiometry), and relevant hormonal/metabolic blood variables were assessed in 59 type 2 diabetic and 42 nondiabetic individuals matched for obesity, sex, and race. Measures were repeated in diabetic participants after weight loss. RESULTS: Metabolic flexibility to glucose (change in respiratory quotient [RQ]) was mainly related to insulin-stimulated glucose disposal rate (R(2) = 0.46, P < 0.0001) with an additional 3% of variance accounted for by plasma free fatty acid concentration at the end of the clamp (P = 0.03). The impaired metabolic flexibility to glucose observed in type 2 diabetic versus nondiabetic subjects (Delta RQ 0.06 +/- 0.01 vs. 0.10 +/- 0.01, respectively, P < 0.0001) was no longer observed after adjusting for glucose disposal rate (P = 0.19). Additionally, the increase in metabolic flexibility to glucose after weight loss was accounted for by the concomitant increase in insulin-stimulated glucose disposal rate. CONCLUSIONS: This study suggests that metabolic inflexibility to glucose in type 2 diabetic subjects is mostly related to defective glucose transport.
OBJECTIVE: Compared with nondiabetic subjects, type 2 diabetic subjects are metabolically inflexible with impaired fasting fat oxidation and impaired carbohydrate oxidation during a hyperinsulinemic clamp. We hypothesized that impaired insulin-stimulated glucose oxidation is a consequence of the lower cellular glucose uptake rate in type 2 diabetes. Therefore, we compared metabolic flexibility to glucose adjusted for glucose disposal rate in nondiabetic versus type 2 diabetic subjects and in the latter group after 1 year of lifestyle intervention (the Look AHEAD [Action For Health in Diabetes] trial). RESEARCH DESIGN AND METHODS: Macronutrient oxidation rates under fasting and hyperinsulinemic conditions (clamp at 80 mU/m(2) per min), body composition (dual-energy X-ray absorptiometry), and relevant hormonal/metabolic blood variables were assessed in 59 type 2 diabetic and 42 nondiabetic individuals matched for obesity, sex, and race. Measures were repeated in diabeticparticipants after weight loss. RESULTS: Metabolic flexibility to glucose (change in respiratory quotient [RQ]) was mainly related to insulin-stimulated glucose disposal rate (R(2) = 0.46, P < 0.0001) with an additional 3% of variance accounted for by plasma free fatty acid concentration at the end of the clamp (P = 0.03). The impaired metabolic flexibility to glucose observed in type 2 diabetic versus nondiabetic subjects (Delta RQ 0.06 +/- 0.01 vs. 0.10 +/- 0.01, respectively, P < 0.0001) was no longer observed after adjusting for glucose disposal rate (P = 0.19). Additionally, the increase in metabolic flexibility to glucose after weight loss was accounted for by the concomitant increase in insulin-stimulated glucose disposal rate. CONCLUSIONS: This study suggests that metabolic inflexibility to glucose in type 2 diabetic subjects is mostly related to defective glucose transport.
Authors: Barbara Ukropcova; Michele McNeil; Olga Sereda; Lilian de Jonge; Hui Xie; George A Bray; Steven R Smith Journal: J Clin Invest Date: 2005-07 Impact factor: 14.808
Authors: Thomas A Wadden; Delia Smith West; Linda Delahanty; John Jakicic; Jack Rejeski; Don Williamson; Robert I Berkowitz; David E Kelley; Christine Tomchee; James O Hill; Shiriki Kumanyika Journal: Obesity (Silver Spring) Date: 2006-05 Impact factor: 5.002
Authors: Martin Mogensen; Kent Sahlin; Maria Fernström; Dorte Glintborg; Birgitte F Vind; Henning Beck-Nielsen; Kurt Højlund Journal: Diabetes Date: 2007-03-09 Impact factor: 9.461
Authors: Barbara Ukropcova; Olga Sereda; Lilian de Jonge; Iwona Bogacka; Tuong Nguyen; Hui Xie; George A Bray; Steven R Smith Journal: Diabetes Date: 2007-03 Impact factor: 9.461
Authors: Juraj Koska; Emilio Ortega; Clifton Bogardus; Jonathan Krakoff; Joy C Bunt Journal: Am J Physiol Endocrinol Metab Date: 2007-07 Impact factor: 4.310
Authors: Amy J Steig; Matthew R Jackman; Erin D Giles; Janine A Higgins; Ginger C Johnson; Chad Mahan; Edward L Melanson; Holly R Wyatt; Robert H Eckel; James O Hill; Paul S MacLean Journal: Am J Physiol Regul Integr Comp Physiol Date: 2011-06-29 Impact factor: 3.619
Authors: Leontine E H Bakker; Bruno Guigas; Linda D van Schinkel; Gerard C M van der Zon; Trea C M Streefland; Jan B van Klinken; Jacqueline T Jonker; Hildo J Lamb; Johannes W A Smit; Hanno Pijl; A Edo Meinders; Ingrid M Jazet Journal: Diabetologia Date: 2014-10-15 Impact factor: 10.122
Authors: Paul S Maclean; Audrey Bergouignan; Marc-Andre Cornier; Matthew R Jackman Journal: Am J Physiol Regul Integr Comp Physiol Date: 2011-06-15 Impact factor: 3.619
Authors: Eric T Trexler; Abbie E Smith-Ryan; Hailee L Wingfield; Malia N Blue; Erica J Roelofs; Katie R Hirsch Journal: J Sports Med Phys Fitness Date: 2016-03-09 Impact factor: 1.637
Authors: Jeanine B Albu; Leonie K Heilbronn; David E Kelley; Steven R Smith; Koichiro Azuma; Evan S Berk; F Xavier Pi-Sunyer; Eric Ravussin Journal: Diabetes Date: 2009-12-22 Impact factor: 9.461
Authors: Ruth C R Meex; Vera B Schrauwen-Hinderling; Esther Moonen-Kornips; Gert Schaart; Marco Mensink; Esther Phielix; Tineke van de Weijer; Jean-Pierre Sels; Patrick Schrauwen; Matthijs K C Hesselink Journal: Diabetes Date: 2009-12-22 Impact factor: 9.461